Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Maaran Michael Rajah Clear advanced filters

  • The SARS-CoV-2 Delta variant partially evades neutralization by several monoclonal antibodies and by sera from individuals who have had COVID-19, but two doses of anti-COVID-19 vaccines still generate a strong neutralizing response.

    • Delphine Planas
    • David Veyer
    • Olivier Schwartz
    Research
    Nature
    Volume: 596, P: 276-280

  • Sera from convalescent individuals with coronavirus disease 2019 and from individuals vaccinated with BNT162b2 have reduced ability to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351, but antibody potency against the variants increases after two vaccine doses.

    • Delphine Planas
    • Timothée Bruel
    • Olivier Schwartz
    Research
    Nature Medicine
    Volume: 27, P: 917-924

  • We demonstrate that the transmembrane protease TMPRSS2 is a receptor for coronavirus HKU1; it triggers HKU1-mediated cell–cell fusion and viral entry by binding to both HKU1A and HKU1B spikes.

    • Nell Saunders
    • Ignacio Fernandez
    • Olivier Schwartz
    Research
    Nature
    Volume: 624, P: 207-214